Company Filing History:
Years Active: 2002-2007
Title: Andrew Braisted: Innovator in Kinase Inhibitor Discovery
Introduction
Andrew Braisted is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of biochemistry, particularly in the discovery of protein kinase inhibitors. With a total of 5 patents to his name, Braisted's work has the potential to impact therapeutic strategies in various diseases.
Latest Patents
Braisted's latest patents include groundbreaking inventions such as the identification of kinase inhibitors. This invention focuses on identifying protein kinase inhibitors that preferentially bind to the inactive conformation of a target protein kinase. The innovative approach involves locking the target protein kinase in an inactive state and using a covalent tethering method to identify inhibitors that specifically target this conformation. Another notable patent is related to methods for ligand discovery. This invention introduces novel techniques for ligand discovery, relying on a process termed 'tethering,' where potential ligands are covalently bonded to a target and subsequently identified.
Career Highlights
Andrew Braisted is currently associated with Sunesis Pharmaceuticals, Inc., where he continues to advance his research in kinase inhibitors. His work is instrumental in developing new therapeutic options for various medical conditions.
Collaborations
Braisted has collaborated with notable colleagues in the field, including Jim Wells and Dan Erlanson. Their combined expertise contributes to the innovative research environment at Sunesis Pharmaceuticals.
Conclusion
Andrew Braisted's contributions to the field of biochemistry, particularly in kinase inhibitor discovery, highlight his role as a leading inventor. His patents and ongoing research efforts are paving the way for advancements in therapeutic strategies.